Category survey

Identification of ALS associated genes using whole genome sequencing Investments > €500k United States of America Motor neurone diseases 2016    

Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Motor and Cognitive Health Outcomes in a Mn-Exposed African Community Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Advanced neural decoders for the restoration of communication Investments > €500k United States of America Motor neurone diseases 2016    

Phase 3 trial of inosine for Parkinsons disease – DCC Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Transgenic Huntingtons disease monkey resource Investments > €500k United States of America Huntington’s disease 2016    

Closed loop deep brain stimulation for Parkinsons disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Genetic Analysis Of Alzheimer s Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Early Cortical Network Markers of AD Risk: a Transcranial Magnetic Stimulation Intervention Trial in Aged Rats Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Oxidative DNA Damage And Its Processing Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Understanding mechanisms and seeking novel biomarkers in Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Inherited Disease, Caregiving, and Social Networks Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mechanism of energy transduction by bacteriorhodopsin Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Clinical Evaluation of PET Radiotracers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Pharmacology of Stimulus Memory and Habit Formation Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Genetic characterization of atypical parkinsonism Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Natural history and biomarker discovery in C9orf72 Amyotrophic lateral sclerosis and frontotemporal dementia Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Biomarkers of Parkinson Disease and Related Disorders Investments > €500k United States of America Alzheimer’s disease & other dementias|Parkinson’s disease & PD-related disorders 2016    

Restoration of olfactory neural circuitry following disruption. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mechanisms of inherited neurodegenerative diseases Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Cyclin-dependent kinase 5 (Cdk5 physiology and pathology) Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects (LEFFTDS) Investments > €500k United States of America Motor neurone diseases 2016    

Phase 3 trial of inosine for Parkinsons disease CCC Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Clinical Coordination Center for STEADY-PD3 Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Data Coordination Center for STEADY-PD3 Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Pacific Northwest Udall Center Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinsons Disease Investments > €500k United States of America Parkinson’s disease & PD-related disorders 2016    

An RCT of an Educational Video to Improve Nursing Home Care in End-Stage Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Translation of COPE for Publicly-Funded Home Care Clients and their Families Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

English Longitudinal Study of Ageing: renewal 2014 Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Harmonized Diagnostic Assessment of Dementia (DAD) for Longitudinal Aging Study of India (LASI) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Caregiving for Alzheimers Disease and Related Dementias: Enhancing the National Study of Caregiving (NSOC) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Functional Assessment using a Virtual Environment Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Defining the Cohort, Outcomes and Predictors for a Prognostic Index for Older Patients with Alzheimers Disease or Related Dementias Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Epidemiology of Alzheimers Disease and Cognition: Innovative Approaches to Global Harmonization Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Harmonized Cognitive and Dementia Assessment in China Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Dementia Prevalence over Time: Proximate Causes and Consequences Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Highly evolved brain circuits in primates: molecular vulnerabilities for disease Investments > €500k United States of America Neurodegenerative disease in general 2016    

Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Genetic etiology of Fronto-Temporal Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Design And Development Of Experimental Therapeutics Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Studies in Dementia and Neurodegenerative Diseases Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Neuroimaging Predictors of Cognitive Decline and Impairment Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Genetic etiology of Amyotrophic Lateral Sclerosis Investments > €500k United States of America Alzheimer’s disease & other dementias|Motor neurone diseases 2016    

Genetic Analysis Of Non-alzheimer Dementias Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Neuroprotective role of GLP-1 receptor agonists Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Immunology of aging and immunotherapy of aging-associated diseases Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Social Regulation of Gene Expression, Supplement Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The Residential Care Transition Module Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The Long-Run Impact of Hurricane Katrina on Mortality, Morbidity and Health Care Cost Among the Elderly Investments > €500k United States of America Alzheimer’s disease & other dementias 2016